189 related articles for article (PubMed ID: 37377953)
1. Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma.
Liu B; Li C; Feng C; Wang H; Zhang H; Tu C; He S; Li Z
Front Immunol; 2023; 14():1178436. PubMed ID: 37377953
[TBL] [Abstract][Full Text] [Related]
2. Integration analysis based on fatty acid metabolism robustly predicts prognosis, dissecting immunity microenvironment and aiding immunotherapy for soft tissue sarcoma.
Liu B; He S; Li C; Feng C; Wang H; Zhang H; Tu C; Li Z
Front Genet; 2023; 14():1161791. PubMed ID: 37065471
[No Abstract] [Full Text] [Related]
3. Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma.
Liu B; Pang K; Feng C; Liu Z; Li C; Zhang H; Liu P; Li Z; He S; Tu C
Front Genet; 2022; 13():1063057. PubMed ID: 36568384
[No Abstract] [Full Text] [Related]
4. Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas.
Long Q; Li Z; Yang W; Huang K; Du G
J Cancer Res Clin Oncol; 2024 Apr; 150(4):203. PubMed ID: 38635069
[TBL] [Abstract][Full Text] [Related]
5. Development of a prognostic Neutrophil Extracellular Traps related lncRNA signature for soft tissue sarcoma using machine learning.
Liu B; He S; Li C; Li Z; Feng C; Wang H; Tu C; Li Z
Front Immunol; 2023; 14():1321616. PubMed ID: 38264665
[TBL] [Abstract][Full Text] [Related]
6. Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs.
Zhang L; Tang X; Wan J; Zhang X; Zheng T; Lin Z; Liu T
Front Mol Biosci; 2021; 8():715764. PubMed ID: 34733885
[No Abstract] [Full Text] [Related]
7. Comprehensive profiling of immune-related genes in soft tissue sarcoma patients.
Hu C; Chen B; Huang Z; Liu C; Ye L; Wang C; Tong Y; Yang J; Zhao C
J Transl Med; 2020 Sep; 18(1):337. PubMed ID: 32873319
[TBL] [Abstract][Full Text] [Related]
8. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
[TBL] [Abstract][Full Text] [Related]
9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
10. Correlative Study on the Relationship between the Expression of m6a-Related Genes and the Prognosis and Immunotherapy of Soft Tissue Sarcoma.
Qiu Y; Li J; Yao J; Meng J; Huang X; Zheng X; Wen Z; Huang J; Wang H
Biomed Res Int; 2022; 2022():5439023. PubMed ID: 38024481
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma.
Lin Z; Pang K; Li H; Zhang X; Wan J; Zheng T; Liu T; Peng W
Front Cell Dev Biol; 2021; 9():709241. PubMed ID: 34631703
[No Abstract] [Full Text] [Related]
12. Identification of Prognostic lncRNA Related to the Immune Microenvironment of Soft Tissue Sarcoma.
Dai WY; Wang B; Li JY; Luo ZP
Biomed Res Int; 2022; 2022():9471558. PubMed ID: 35155682
[TBL] [Abstract][Full Text] [Related]
13. A New Signature of Sarcoma Based on the Tumor Microenvironment Benefits Prognostic Prediction.
Zhang G; Jian A; Zhang Y; Zhang X
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769292
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma.
Qi L; Xu R; Wan L; Ren X; Zhang W; Zhang K; Tu C; Li Z
Front Genet; 2021; 12():773373. PubMed ID: 34925457
[TBL] [Abstract][Full Text] [Related]
15. A Combined Risk Score Model to Assess Prognostic Value in Patients with Soft Tissue Sarcomas.
Li Z; Duan Z; Jia K; Yao Y; Liu K; Qiao Y; Gao Q; Yang Y; Li G; Shang A
Cells; 2022 Dec; 11(24):. PubMed ID: 36552841
[TBL] [Abstract][Full Text] [Related]
16. Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma.
Qi L; Zhang W; Ren X; Xu R; Yang Z; Chen R; Tu C; Li Z
Front Immunol; 2022; 13():921223. PubMed ID: 35860263
[TBL] [Abstract][Full Text] [Related]
17. A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas.
Liu B; Liu Z; Feng C; Tu C
Front Genet; 2022; 13():899545. PubMed ID: 35795204
[No Abstract] [Full Text] [Related]
18. Bioinformatics analysis reveals the competing endogenous RNA (ceRNA) coexpression network in the tumor microenvironment and prognostic biomarkers in soft tissue sarcomas.
Zou D; Wang Y; Wang M; Zhao B; Hu F; Li Y; Zhang B
Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33587010
[TBL] [Abstract][Full Text] [Related]
19. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S
Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of ferroptosis in soft tissue sarcoma constructs a prognostic and immunotherapeutic signature through experimental and bioinformatics analyses.
Yang ZQ; Guo LY; Xiao KW; Zhang C; Wu MH; Yan FF; Cai L
Aging (Albany NY); 2023 Oct; 15(20):11412-11447. PubMed ID: 37874682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
